Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy

• Main Authors: Wiebke Sihver (Author), Jens Pietzsch (Author), Mechthild Krause (Author), Michael Baumann (Author), Jörg Steinbach (Author), Hans-Jürgen Pietzsch (Author)
• Format: Book
• Published: MDPI AG, 2014-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The epidermal growth factor receptor (EGFR) has evolved over years into a main molecular target for the treatment of different cancer entities. In this regard, the anti-EGFR antibody cetuximab has been approved alone or in combination with: (a) chemotherapy for treatment of colorectal and head and n...